Skip to main content
36°
Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Viking Therapeutics, Inc. - Common Stock
(NQ:
VKTX
)
29.75
+0.20 (+0.68%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 13, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Viking Therapeutics, Inc. - Common Stock
< Previous
1
2
...
11
12
13
14
15
16
17
18
19
...
22
23
Next >
1 Wall Street Analyst Thinks Viking Therapeutics Stock Is Going to $116. Is It a Buy Around $81?
March 04, 2024
It could have even further to rise after its massive run-up.
Via
The Motley Fool
Beyond the "Mag 7": 3 Risk-On Market Forces
March 03, 2024
The biggest bear argument over the past year has been slim leadership in the market, namely concentrated in mega-cap tech stocks such as the “Mag 7.” However, dig deeper, and you will discover there's...
Via
Talk Markets
Better Buy: Eli Lilly vs. Viking Therapeutics
March 03, 2024
These two biotechs could eventually go head to head in a fast-growing market.
Via
The Motley Fool
Missed Out on Novo Nordisk Stock? Buy This 1 Biotech Stock Right Now.
March 03, 2024
The battle for the obesity therapies market is escalating.
Via
The Motley Fool
Why Novo Nordisk Stock Topped the Market Today
March 01, 2024
A favorite of both investors and analysts gets a boost from a bullish move by a pundit.
Via
The Motley Fool
Stock Market Rally At Highs After Big Earnings, Inflation Data: Weekly Review
March 01, 2024
The Nasdaq is on the cusp of setting a record high.
Via
Investor's Business Daily
Topics
Economy
Exposures
Interest Rates
Here's How Much $1000 Invested In Viking Therapeutics 5 Years Ago Would Be Worth Today
February 29, 2024
Via
Benzinga
Eli Lilly Stock And The Road To 1,000: Weight-Loss Drugs Could Generate $81 Billion
March 01, 2024
Wall Street isn't properly taking into account Lilly's next-generation drugs, an analyst says.
Via
Investor's Business Daily
2 Stocks That Could Turn $1,000 Into $2,500 in 5 Years
March 01, 2024
It will take a lot, but this goal isn't out of reach for these stocks.
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
February 29, 2024
Via
Benzinga
Viking Therapeutics: A Teachable Moment About Investing for the Long Term
February 29, 2024
The biotherapeutics company's weight loss candidate scored a major win this week.
Via
The Motley Fool
Viking Therapeutics Just Soared 120% on Optimism About Its Weight Loss Candidate. Too Late to Buy?
February 29, 2024
Viking stock surged in the triple digits in one trading session.
Via
The Motley Fool
Behind the Scenes of Viking Therapeutics's Latest Options Trends
February 28, 2024
Via
Benzinga
Is Viking Therapeutics a Buy Now?
February 29, 2024
The stock recently jumped more than 100% overnight thanks to surprising results from its anti-obesity candidate.
Via
The Motley Fool
Biotech Stocks Surge To Start 2024: 'Charts Look Great,' But Will The Trend Continue?
February 28, 2024
The biotech sector has been surging in recent months, reawakening from a period of underperformance that followed the highs of 2021. David Prince, professional trader at T3 Trading Group, joined...
Via
Benzinga
TG Therapeutics Soars On In-Line Report; Is The Biotech Rally Buoying Shares?
February 28, 2024
The company reported in-line sales for the fourth quarter, but shares soared by double digits.
Via
Investor's Business Daily
Viking Therapeutics' Weight Loss Study Data Outperformed Novo Nordisk, Eli Lilly Studies, Analysts Say
February 28, 2024
Viking Therapeutics achieves significant weight loss in the VENTURE trial, outperforming rivals in body weight reductions.
Via
Benzinga
Jim Cramer Weighs In On Palo Alto, Eli Lilly And Salesforce, Says Price Target Bump For This Stock A 'Red Flag'
February 28, 2024
During Tuesday's CNBC Investing Club Morning Meeting, U.S. stocks exhibited mixed performance, prompting a closer look at prevailing market themes. Cybersecurity emerged as a key focus, with Jim Cramer...
Via
Benzinga
Beyond Meat, Viking Therapeutics, Novavax, Baidu, Tesla: Why These 5 Stocks Are On Investors' Radars Today
February 27, 2024
The U.S. indices were mixed with the S&P 500 rising by nearly 0.2% to 5,078.18 and the Dow Jones Industrial Average falling by 0.25% to 38,972.41.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Novo Nordisk and Eli Lilly Stocks Slipped Today
February 27, 2024
A competitor to Wegovy and Zepbound might appear on pharmacy shelves before long.
Via
The Motley Fool
Stocks Are “Coiling” Near All-Time Highs - Mania Could Be Next
February 27, 2024
If you’ve gotten the sense lately that something is building, you’re not wrong. We’ve seen hyper-concentration in the biggest stocks, to the point where plenty of us are focused on just one.
Via
Talk Markets
Dow Dips Over 100 Points; J.M. Smucker Posts Upbeat Earnings
February 27, 2024
U.S. stocks traded mixed toward the end of trading, with the Dow Jones index falling more than 100 points on Tuesday. The Dow traded down 0.35% to 38,932.26 while the NASDAQ rose 0.28% to 16,021.41....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
S&P 500, Nasdaq 100 Dip, Small Caps Surge; Bitcoin Tops $57,000, 2 Biotech Stocks Skyrocket: What's Driving Markets Tuesday?
February 27, 2024
On Tuesday, large-cap indices experienced a downturn, while small caps surged, reflecting investor attention on stock valuations.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is Ligand Pharmaceuticals Stock Trading Higher Today?
February 27, 2024
Ligand Pharmaceuticals beats Q4 2023 sales estimates at $28.1 million, with strong core Captisol and royalty figures. CEO Todd Davis highlights transformative 2023 and optimistic guidance for 2024.
Via
Benzinga
Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
February 27, 2024
Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
February 27, 2024
Via
Benzinga
Crude Oil Gains 1%; Macy's Plans To Close 150 Stores
February 27, 2024
U.S. stocks traded mixed midway through trading, with the Dow Jones index falling around 150 points on Tuesday. The Dow traded down 0.39% to 38,915.65 while the NASDAQ rose 0.15% to 15,999.50. The S&P...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
3 Biotech Stocks Bound to Blast Off By 2029
February 27, 2024
Biotech stocks are risky, but rewarding. These three biotechs specifically could see exponential gains in the coming years.
Via
InvestorPlace
Anheuser-Busch Strike: 5 Things to Know as Brewers Gear Up for Walkout
February 27, 2024
An Anheuser-Busch strike is brewing as the beer company continues troubled negotiations with members of the Teamsters union.
Via
InvestorPlace
Norwegian Cruise Line Posts Strong Sales, Joins Hims & Hers Health, Sterling Infrastructure And Other Big Stocks Moving Higher On Tuesday
February 27, 2024
U.S. stocks were mixed, with the Dow Jones index falling around 100 points on Tuesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
< Previous
1
2
...
11
12
13
14
15
16
17
18
19
...
22
23
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.